Apr 09, 2020
Infant Fecal pH Revealed as a Critical Indicator of Infant Gut Health and Resistance against Gut Pathogen Invasion
Nov 01, 2019
Revenue Forecasts for the Top Twelve Probiotics Manufacturers, 2019-2024
Sep 10, 2019
Intestinal Inflammation in Infants Dramatically Reduced with Bifidobacterium infantis
Jun 10, 2019
Probiotic Ingredients Market Will Observe Just-above 6% CAGR Over 2019 to 2027 - Future Market Insights
Jan 31, 2019
The Global Market for Probiotic Ingredients, 2018-2023 - Increasing Demand for Probiotics in Developed Economies Presents Lucrative Opportunities
Oct 22, 2018
Anaeropharma Science Signs Collaborative Research Agreement with Chugai on Creation of Novel Oncology Drugs Using Bifidobacterium
Oct 10, 2018
UC Davis Scientific Team Strengthens Case for Bifidobacterium in the Fight Against Antibiotic Resistance
Sep 25, 2018
Anaeropharma Science Signs Collaborative Research Agreement with Astellas on Creation of Novel Anti-Tumor Drugs Using Bifidobacterium
Sep 20, 2018
First-Ever Rapid Response Test for Levels of Bifidobacterium in Baby's Gut Microbiome
Sep 18, 2018
New Study Reveals Activated B. Infantis EVC001 Reduces Colonic Mucin Degradation in Babies
Apr 17, 2018
Landmark Study To Address Global Malnutrition And Restorative Effect Of Infant Probiotic
Mar 07, 2018
New Study Shows Significant Changes to Infant Fecal pH Over Last 100 Years
Feb 28, 2018
Kibow® Fortis Recently Featured at the 2018 Integrative Healthcare Symposium in New York, NY
Sep 06, 2017
Global Probiotics Council Awards The 2017 Young Investigator Grants For Probiotic Research